| 注册
首页|期刊导航|临床肝胆病杂志|原发性肝癌综合介入治疗现状与困惑

原发性肝癌综合介入治疗现状与困惑

梁宏元 卢再鸣

临床肝胆病杂志Issue(1):44-48,5.
临床肝胆病杂志Issue(1):44-48,5.DOI:10.3969/j.issn.1001-5256.2016.01.006

原发性肝癌综合介入治疗现状与困惑

Current status and confusion in comprehensive interventional therapy for hepatocellular carcinoma

梁宏元 1卢再鸣1

作者信息

  • 1. 中国医科大学附属盛京医院 放射科,沈阳 110001
  • 折叠

摘要

Abstract

In recent years,hepatocellular carcinoma (HCC)has become the second leading cause of cancer-related death worldwide.Due to the insidious onset of this disease,only 20%-30%of the patients with HCC have the opportunity for surgical resection or liver transplan-tation.At present,interventional therapy has become the first choice for patients with intermediate-stage HCC and some patients with late-stage HCC,and more and more scholars have realized the importance and necessity of comprehensive interventional therapy for HCC.The comprehensive interventional therapy of transcatheter arterial chemoembolization (TACE)in combination with various methods (TACE com-bined with local treatment,TACE sequential surgery,or TACE combined with systemic treatment)provides many therapeutic approaches and achieves good therapeutic effects.However,the indications,timing,and recurrence and metastasis after treatment for such combination ther-apies await further investigation.

关键词

肝肿瘤/放射学,介入性/化学栓塞,治疗性/综合疗法

Key words

liver neoplasms/radiology,interrentional/chemoembolization,therapeutic/combined modality therapy

分类

医药卫生

引用本文复制引用

梁宏元,卢再鸣..原发性肝癌综合介入治疗现状与困惑[J].临床肝胆病杂志,2016,(1):44-48,5.

临床肝胆病杂志

OACSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文